Actual Medicinal Product (AMP) Colofac 135mg tablets (Mawdsley-Brooks & Company Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from moisture.
Protect from light. Protect from heat.
Manufacturer recommends storing in original container Stability data for 5 weeks in a sealed MCA. - Provenance
-
This recommendation is based on the products Colofac 135mg tablets (Viatris Healthcare Limited) and Mebeverine 135mg tablets (Aurobindo Pharma-Milpharm Ltd).
- Generic
- Mebeverine
- Formulation
- Mebeverine 135mg tablets
-
Mebeverine
-
Mebeverine 135mg tablets
-
Colofac 135mg tablets (Mawdsley-Brooks & Company Ltd)
-
-
Mebeverine 100mg tablets